| Storch A, Jost W, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H, for the German Coenzyme Q10 Study Group, 2007, Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson's disease, Arch. Neurol. 64: 938-944. |
| Weber YG$, Storch A$, Wuttke T$, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy F, Münchau A, Edwards MJ, Presicci A, Margari F, Gasser T, Lang F, Bhatia KP, Lehmann-Horn F, Lerche H, 2008, GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak, J. Clin. Invest. 118(6): 2157-2168. |
| Hermann A, Suess C, Fauser M, Kanzler S, Witt M, Fabel K, Schwarz J, Höglinger GU, Storch A, 2009, Rostro-caudal gradual loss of cellular diversity within the periventricular regions of the ventricular system, Stem Cells 27(4): 928-941. |
| Storch A, Schneider CB, Wolz M, Stürwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G, 2013, Nonmotor fluctuations in Parkinson's disease: Severity and correlation with motor complications, Neurology 80: 800-809 [Editorial: Antonini A, Albin RL, 2013, Neurology 80: 784-785]. |
| Löhle M, Mende J, Wolz M, Beuthien-Baumann B, Oehme L, van den Hoff J, Kotzerke J, Reichmann H, Storch A, 2016, Putaminal dopamine turnover in de novo Parkinson's disease predicts later motor complications, Neurology 86(3): 231-240 [Recommended by the "Faculty of 1000"]. |
)